Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership32,685 shares
Latest Disclosed Value $ 738,681
Squarepoint Ops LLC reports 43.01% decrease in ownership of PCRX / Pacira BioSciences, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 32,685 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $738,681 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 57,349 shares of Pacira BioSciences, Inc.. This represents a change in shares of -43.01% during the quarter. The current value of the position is $729,529 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 32,685 -24,664 -43.01 739 -50.27 0.0009
2026-02-13 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 57,349 4,996 9.54 1,484 10.01 0.0016
2025-11-14 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 52,353 30,946 144.56 1,349 163.99 0.0014
2025-08-27 2025-06-30 13F/A-1 PACIRA BIOSCIENCES COM 695127100 21,407 21,407 512 0.0005
2025-08-14 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 21,407 21,407 512 0.0005
2025-08-27 2025-03-31 13F/A-1 PACIRA BIOSCIENCES COM 695127100 0 -60,836 -100.00 0 -100.00
2025-05-15 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 0 -60,836 0
2025-02-14 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 60,836 25,505 72.19 1,146 115.82 0.0011
2024-11-14 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 35,331 6,823 23.93 532 -34.85 0.0008
2024-08-14 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 28,508 6,794 31.29 816 28.55 0.0013
2024-05-15 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 21,714 21,714 634 0.0011
2023-11-14 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 0 -20,715 -100.00 0 -100.00
2023-08-14 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 20,715 20,715 830 0.0025
2023-05-15 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 0 -13,252 -100.00 0 -100.00
2023-02-14 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 13,252 86 0.65 512 -27.00 0.0020
2022-11-14 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 13,166 -1,377 -9.47 700 -17.45 0.0035
2022-08-15 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 14,543 -26,663 -64.71 848 -73.04 0.0047
2022-05-16 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 41,206 -4,886 -10.60 3,145 13.42 0.0135
2022-02-14 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 46,092 -13,327 -22.43 2,773 -16.65 0.0073
2021-11-15 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 59,419 25,064 72.96 3,327 59.57 0.0096
2021-08-16 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 34,355 34,355 2,085 0.0079
2021-05-17 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 0 -15,336 -100.00 0 -100.00
2021-02-16 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 15,336 -10,985 -41.73 918 -41.97 0.0069
2020-11-16 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 26,321 16,906 179.56 1,582 220.24 0.0213
2020-08-14 2020-06-30 13F PACIRA BIOSCIENCES COM 695127100 9,415 9,415 -64.23 494 -68.77 0.0080
2020-05-15 2020-03-31 13F PACIRA BIOSCIENCES COM 695127100 0 -39,656 -100.00 0 -100.00
2020-02-14 2019-12-31 13F PACIRA BIOSCIENCES COM 695127100 39,656 7,751 24.29 1,796 47.82 0.0107
2019-11-14 2019-09-30 13F PACIRA BIOSCIENCES COM 695127100 31,905 -2,835 -8.16 1,215 -19.59 0.0108
2019-08-14 2019-06-30 13F PACIRA BIOSCIENCES COM 695127100 34,740 -81,810 -70.19 1,511 -65.94 0.0147
2019-05-15 2019-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 116,550 81,822 235.61 4,436 196.92 0.0470
2019-02-14 2018-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 34,728 12,450 55.88 1,494 36.44 0.0174
2018-11-14 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 22,278 11,289 102.73 1,095 211.08 0.0131
2018-08-14 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 10,989 10,989 -50.67 352 -67.85 0.0047
2018-05-15 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 -10,680 -100.00 0 -100.00
2018-02-14 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 10,680 10,680 488 0.0085
2017-02-14 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 -28,592 -100.00 0 -100.00
2016-11-14 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 28,592 28,592 0.00 978 0.0649
2016-02-16 2015-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 0 -13,100 -100.00 0 -100.00
2015-11-16 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 13,100 13,100 538 0.1343
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.